Allogene Therapeutics, Inc. (ALLO)
1.325
0.00 (0.00%)
USD |
NASDAQ |
Oct 21, 16:00
1.325
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Market Cap : 457.58M for Oct. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 459.31M |
| October 19, 2026 | 448.95M |
| October 16, 2026 | 452.40M |
| October 15, 2026 | 462.76M |
| October 14, 2026 | 448.95M |
| October 13, 2026 | 445.50M |
| October 12, 2026 | 483.48M |
| October 09, 2026 | 504.20M |
| October 08, 2026 | 483.48M |
| October 07, 2026 | 493.84M |
| October 06, 2026 | 504.20M |
| October 05, 2026 | 518.02M |
| October 02, 2026 | 518.02M |
| October 01, 2026 | 531.83M |
| September 30, 2026 | 552.55M |
| September 29, 2026 | 559.46M |
| September 28, 2026 | 562.91M |
| September 25, 2026 | 569.82M |
| September 24, 2026 | 576.73M |
| September 23, 2026 | 576.73M |
| September 22, 2026 | 590.54M |
| September 21, 2026 | 583.63M |
| September 18, 2026 | 583.63M |
| September 17, 2026 | 597.45M |
| September 16, 2026 | 583.63M |
| Date | Value |
|---|---|
| September 15, 2026 | 593.99M |
| September 14, 2026 | 614.71M |
| September 11, 2026 | 614.71M |
| September 10, 2026 | 607.81M |
| September 09, 2026 | 597.45M |
| September 08, 2026 | 642.34M |
| September 04, 2026 | 680.33M |
| September 03, 2026 | 683.78M |
| September 02, 2026 | 683.78M |
| September 01, 2026 | 685.51M |
| August 31, 2026 | 690.69M |
| August 28, 2026 | 697.60M |
| August 27, 2026 | 721.77M |
| August 26, 2026 | 704.50M |
| August 25, 2026 | 749.40M |
| August 24, 2026 | 701.05M |
| August 21, 2026 | 721.77M |
| August 20, 2026 | 725.23M |
| August 19, 2026 | 770.12M |
| August 18, 2026 | 701.05M |
| August 17, 2026 | 718.32M |
| August 14, 2026 | 707.96M |
| August 13, 2026 | 683.78M |
| August 12, 2026 | 714.86M |
| August 11, 2026 | 732.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.303B |
| Oncolytics Biotech, Inc. | 64.09M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.961B |
| Anixa Biosciences, Inc. | 93.90M |
Market Cap Related Metrics
| PS Ratio | 72.62 |
| Price to Book Value | 1.049 |
| Price | 1.325 |
| Earnings Yield | -50.20% |